From Medscape Oncology

Medscape Medical News from the

Genitourinary Cancers Symposium (GUCS) 2015

February 26 - 28, 2015; Orlando, Florida

Conference News

$Pazopanib and Paclitaxel Active in Refractory Bladder Cancer$ GUCS Pazopanib and Paclitaxel Active in Refractory Bladder Cancer
Medscape Medical News, March 6, 2015
GUCS High BMI Boosts Survival in Metastatic Renal Cancer
Medscape Medical News, March 4, 2015
GUCS Profiling Reveals Potential Targets in Rare Bladder Cancer
Medscape Medical News, March 4, 2015
GUCS Ramucirumab Plus Docetaxel Improves Outcomes in Bladder Cancer
Medscape Medical News, March 2, 2015
GUCS Novel Combination 'Encouraging' in Advanced Kidney Cancer
Medscape Medical News, March 2, 2015
GUCS MiR-371 Promising New Marker in Testicular Germ Cell Tumors
Medscape Medical News, March 2, 2015

GUCS AR-V7 Status Not Associated With Taxane Resistance in mCRPC
Medscape Medical News, February 25, 2015
GUCS Cautionary Tale in Long-Term Surveillance of Prostate Cancer
Medscape Medical News, February 24, 2015
GUCS VEGF Inhibitors Disappoint in Adjuvant Renal Cell Carcinoma
Medscape Medical News, February 24, 2015
GUCS Testicular Cancer Ups Rates of Risky Prostate Cancer Later On
Medscape Medical News, February 24, 2015
GUCS Higher-Risk Prostate Cancers in US May Have Increased
Medscape Medical News, February 23, 2015

Medscape Oncology© WebMD, LLC

Previous Coverage

Resource Center

Genitourinary, Prostate Cancer News & Perspectives